Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Ide-cel induced responses in a majority of heavily pretreated patients with refractory and relapsed myeloma; MRD-negative status was achieved in 26% of treated patients. Almost ...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,137
- Institution
- Princess Margaret Cancer Centre
External Links
Identifiers
- ORCID
- 0009-0002-9686-4323
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.